Literature DB >> 10801868

Comparing and contrasting Escherichia coli and Mycobacterium tuberculosis mechanosensitive channels (MscL). New gain of function mutations in the loop region.

J A Maurer1, D E Elmore, H A Lester, D A Dougherty.   

Abstract

Sequence analysis of 35 putative MscL homologues was used to develop an optimal alignment for Escherichia coli and Mycobacterium tuberculosis MscL and to place these homologues into sequence subfamilies. By using this alignment, previously identified E. coli MscL mutants that displayed severe and very severe gain of function phenotypes were mapped onto the M. tuberculosis MscL sequence. Not all of the resulting M. tuberculosis mutants displayed a gain of function phenotype; for instance, normal phenotypes were noted for mutations at Ala(20), the analogue of the highly sensitive Gly(22) site in E. coli. A previously unnoticed intersubunit hydrogen bond in the extracellular loop region of the M. tuberculosis MscL crystal structure has been analyzed. Cross-linkable residues were substituted for the residues involved in the hydrogen bond, and cross-linking studies indicated that these sites are spatially close under physiological conditions. In general, mutation at these positions results in a gain of function phenotype, which provides strong evidence for the importance of the loop region in MscL channel function. No analogue to this interesting interaction could be found in E. coli MscL by sequence alignment. Taken together, these results indicate that caution should be exercised in using the M. tuberculosis MscL crystal structure to analyze previous functional studies of E. coli MscL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801868     DOI: 10.1074/jbc.M003056200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Structural determinants of MscL gating studied by molecular dynamics simulations.

Authors:  J Gullingsrud; D Kosztin; K Schulten
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

2.  Molecular dynamics simulations of wild-type and mutant forms of the Mycobacterium tuberculosis MscL channel.

Authors:  D E Elmore; D A Dougherty
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

3.  Gating the bacterial mechanosensitive channel MscL invivo.

Authors:  Ann Finney Batiza; Mario Meng-Chiang Kuo; Kenjiro Yoshimura; Ching Kung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  Loss-of-function mutations at the rim of the funnel of mechanosensitive channel MscL.

Authors:  Kenjiro Yoshimura; Takeshi Nomura; Masahiro Sokabe
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

5.  Purification and functional reconstitution of N- and C-halves of the MscL channel.

Authors:  Kyu-Ho Park; Catherine Berrier; Boris Martinac; Alexandre Ghazi
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

Review 6.  The MscS and MscL families of mechanosensitive channels act as microbial emergency release valves.

Authors:  Ian R Booth; Paul Blount
Journal:  J Bacteriol       Date:  2012-06-08       Impact factor: 3.490

7.  The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis.

Authors:  Lakmal Jayasinghe; Hagan Bayley
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

8.  Mechanosensitive membrane channels in action.

Authors:  Serge Yefimov; Erik van der Giessen; Patrick R Onck; Siewert J Marrink
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

9.  Conserved motifs in mechanosensitive channels MscL and MscS.

Authors:  Daniel Balleza; Froylan Gómez-Lagunas
Journal:  Eur Biophys J       Date:  2009-05-08       Impact factor: 1.733

10.  The role of the periplasmic loop residue glutamine 65 for MscL mechanosensitivity.

Authors:  I-Jung Tsai; Zhen-Wei Liu; John Rayment; Christel Norman; Allan McKinley; Boris Martinac
Journal:  Eur Biophys J       Date:  2005-04-06       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.